Memorial Slaon-Kettering Cancer Center

New York, New York 10065

0 studies enrolling now · 3 studies all time

What they study most

HER2-positive Carcinoma, HER2-positive Primary Malignancy, HIV Infections, Mental Health, Multiple Myeloma

Studies at this site

• First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody — Completed
• Imaging With a New Agent That Finds a Cancer Protein Called HER2 — Completed
• Evaluation of Enrollment, Dynamics of Care and Patient Outcomes in the NYS Medicaid HIV Special Needs Plans — Completed